Impact of Gastrointestinal Disease on the Risk of Low-Dose Acetylsalicylic Acid Discontinuation

May-11

AUTHORS : Dr Luis A. Garcia Rodríguez, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Almirante 28, 28004 Madrid, Spain – Email: lagarcia@ceife.es – Profile: http://www.ceife.es/quienes-somos.html

JOURNAL : Gastroenterology

REFERENCE: 140(5):S585

DOI : 10.1016/S0016-5085(11)62421-9

Impact of Gastrointestinal Disease on the Risk of Low-Dose Acetylsalicylic Acid Discontinuation

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Colonic Diverticulosis and Uncomplicated Diverticulitis Are Associated With a Lower Not Higher Risk of Mortality When Confounding Factors Are Held Constant

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement